Gufic Biosciences Limited

445.55

INR
+8.05(+1.84%)
As of November 14, 2024 10:00:00 AM

About Gufic Biosciences Limited

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
5.41x
Operating MarginLast 12 months
15.52
+1.0999999999999999% quarterly YoY
Market Cap
4402.71 CrINR
Employees
1491
CEO
Mr. Pranav Jayesh Choksi
Website

Gufic Biosciences Limited

445.55

INR
+8.05(+1.84%)
As of November 14, 2024 10:00:00 AM

About Gufic Biosciences Limited

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
5.41x
Operating MarginLast 12 months
15.52
+1.0999999999999999% quarterly YoY
Market Cap
4402.71 CrINR
Employees
1491
CEO
Mr. Pranav Jayesh Choksi
Website